Philip Schoenfeld, MD, MSEd, MSc, Associate Professor, Department of Internal Medicine, University of Michigan School of Medicine, discusses treatments for constipation associated irritable bowl syndrome.

Dr. Schoenfeld has disclosed the following: Consulting Fees: Salix, Novartis, Takeda, AGI, Therapeutics Ownership Interest: Wyeth Other: MD Evidence (Partner)

References and Resources
Cash BD, Chey WD. Advances in the management of irritable bowel syndrome. Curr Gastroenterol Rep. Dec 2003. 5(6):468-75.

Frissora CL. Nuances in treating irritable bowel syndrome. Rev Gastroenterol Disord. 2007. Spring;7(2):89-96.

Tolliver BA, Herrera JL, DiPalma JA. Evaluation of patients who meet clinical criteria for irritable bowel syndrome. Am J Gastroenterol. Feb 1994;89(2):176-8.

Sponsored by The Doctor’s Channel